Make oncology research personalized with clinicogenomics data

ABOUT COTA's CLINICOGENOMICS PRODUCT

Augment deep clinical data with comprehensive genomic profiling, fueling your team’s early discovery and translational epidemiology efforts.

COTA’s clinicogenomics product covers:

 

USE CASES

Data includes both standard of care and emerging biomarkers. Information on emerging biomarkers can enable:

 

ABOUT COTA

Bringing clarity to cancer

Founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real-world data. COTA curates t-for-purpose, regulatory-grade oncology RWD from structured and unstructured EHR data that is used across the drug development lifecycle.

Our data is ready for analysis and contains clear longitudinal patients journeys that support regulatory submissions and research questions including treatment patterns, real-world outcomes, and comparisons.

0
million
Cancer lives in our network
0
+
Oncologists across our network
0
FDA and EMA approvals
0
+
Genes molecularly profiled

Contact Us for More Information

  • This field is for validation purposes and should be left unchanged.

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.